Astrego is a rapidly growing in vitro diagnostic company based in Uppsala, Sweden. After a decade of fundamental research, the company was founded in March 2017 with the mission to help in the global fight against antimicrobial resistance (AMR).
The company name comes from Antibiotic Susceptibility Testing – AST, and rego – being latin for guide, steer or manage. Our products are designed to guide physicians in the selection of effective antibiotic treatments to improve patient outcomes and make antibiotic stewardship easy.
